REICIN ALISE
Chief Executive Officer
REICIN ALISE has filed 7 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Jun 23, 2026.
On the most recent filing, REICIN ALISE is listed as Chief Executive Officer at Tectonic Therapeutic, Inc. Inside the rolling window, REICIN ALISE reported 1 open-market purchase totaling $53K in TECX and no open-market sales.
Companies traded
Other insiders at TECX
Insider Buying
$53K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has REICIN ALISE made?
REICIN ALISE has filed 7 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does REICIN ALISE trade?
REICIN ALISE has filed SEC Form 4 disclosures for 1 company, including TECX.
When was REICIN ALISE's most recent SEC Form 4 filing?
REICIN ALISE's most recent SEC Form 4 filing on Tracefour is dated Jun 23, 2026.
What is REICIN ALISE's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, REICIN ALISE is listed as Chief Executive Officer.
What is REICIN ALISE's total buy and sell value in the current window?
Inside the rolling retention window, REICIN ALISE bought $53K and sold $0 based on SEC Form 4 filings.
What was REICIN ALISE's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,500 TECX shares on 2026-02-11, worth $53K, per SEC Form 4 filings.